GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Change In Other Working Capital

FibroBiologics (FibroBiologics) Change In Other Working Capital : $0.02 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Change In Other Working Capital?

FibroBiologics's Change In Other Working Capital for the quarter that ended in Mar. 2024 was $-0.10 Mil. It means FibroBiologics's Other Working Capital declined by $0.10 Mil from Dec. 2023 to Mar. 2024 .

FibroBiologics's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $-0.31 Mil. It means FibroBiologics's Other Working Capital declined by $0.31 Mil from Dec. 2022 to Dec. 2023 .


FibroBiologics Change In Other Working Capital Historical Data

The historical data trend for FibroBiologics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Change In Other Working Capital Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Change In Other Working Capital
-0.02 -0.23 -0.31

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only -0.16 -0.03 0.10 0.05 -0.10

FibroBiologics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines